3933 — United Laboratories International Holdings Share News
0.000.00%
Last trade - 00:00- HK$14.32bn
- HK$8.41bn
- CNY13.21bn
United Laboratories drops as major shareholder plans share sale at discount
Brief: United Laboratories International Says Controlling Shareholder Entered Placing Agreement
Brief: United Laboratories International Says Approval For Clinical Trial By NMPA Of China
Brief: United Laboratories International Announces Approval For Clinical Trial By NMPA Of China
Brief: United Laboratories International Says Meropenem For Injection Submitted Passed Evaluation
Brief: United Laboratories International Says Ibuprofen Sustained Release Capsules Passed Evaluation
Brief: United Laboratories International Declared Interim Dividend Of RMB12 Cents Per Ordinary Share
Brief: United Laboratories International Posts HY Profit Attributable RMB1.28 Billion
Brief: United Laboratories International Application For Clinical Trial Of Ubt251 Approved By NMPA
Brief: United Laboratories International Says Application For Marketing Of Liraglutide Injection Accepted
Brief: United Laboratories International Sees Net Profit Of RMB1.20 Billion For Six Months
Brief: United Laboratories International Updates On Piperacillin Sodium And Tazobactam Sodium For Injection
Brief: United Laboratories International Says UBT251 Injection Obtained Acceptance Notices By China NMPA
Brief: United Laboratories International Says Unit Received Approval Of Clinical Trial By NMPA
Brief: United Laboratories International Posts FY Profit Attributable RMB1.58 Billion
HK-listed United Laboratories hits 6-week high on robust earnings forecast
Brief: United Laboratories International Sees Profit Of Approximately Rmb1.5 Billion For Year
Brief: United Laboratories Says Application For Clinical Trial Of Class 1 New Drug Tul12101 Eye Drops Approved
Brief: United Laboratories International Announces Loan Facility With Hang Seng Bank